InVivo Therapeutics

InVivo Therapeutics Corporation is a medical device company focused on utilizing polymers as a platform technology to develop treatments to restore function in individuals paralyzed as a result of traumatic spinal cord injuries.

The company was founded in 2005 on the basis of research initiated in Cambridge, Massachusetts, United States.

InVivo Therapeutics headquartered in United States, North America, operates in the Biotechnology, Health Care, Medical Device, Therapeutics sector. The company focuses on Biotechnology and has secured $18.0B in funding across 144 round(s). With a team of 1-10 employees, InVivo Therapeutics is actively contributing to advancements in Biotechnology. Their latest funding round, Post-IPO Equity - InVivo Therapeutics, raised $13.0M. Discover more about their projects, partnerships, and impact on our platform.